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ABSTRACT 
 
Aim 
The aim was to explore stakeholder views on the impact of nurse prescribing on 
dermatology services.   
Background 
Nurse led care enhances the services that dermatology patients receive. Research 
indicates that care delivered by nurse prescribers can improve efficiency and access to 
medicines. There is no evidence exploring the impact of nurse prescribing on the 
configuration of dermatology services 
Method 
A collective case study of 10 practice settings across England in which nurses 
prescribed medicines for dermatology patients. A thematic analysis of semi-structured 
interview data collected during 2006 and 2007. Participants were qualified nurse 
prescribers, administrative staff, doctors and non-nurse prescribers.  
Findings 
Nurse prescribing was reported to support and facilitate the modernisation of 
dermatology services. It enabled nurses to make effective use of their knowledge and 
skills, overcome delays in treatment and provide faster access to medicines. However 
a number of organizational issues restricted the success of the initiative.  
Conclusion 
Nurse prescribing is successfully being used to support and deliver a range of services 
to dermatology patients.  Stakeholders reported that both patients and staff had 
benefited by the adoption of this role by nurses.  However issues over support and 
access to CPD, and capacity of the workforce were identified as potential barriers 
which could affect the contribution of nurse prescribing to dermatology patients.   
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IMPLICATIONS FOR CLINICAL PRACTICE 
 Nurse prescribing contributes to the services provided to dermatology patients 
 Nurse supplementary prescribing contributes to the ability of  dermatology 
nurse specialists to work in teams and prescribe complex medicines  
 Provision of adequate support and strategic planning are essential if the impact 
of nurse prescribing is to be fully realised 
 
Key words: nurse prescribing, dermatology, services 
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INTRODUCTION 
Skin disease affects 22-33% of the population, and the prevalence of common skin 
conditions, e.g. leg ulcers, skin cancer and atopic eczema is increasing (Department of 
Health (DoH) 2007).  Large numbers of people with mild forms of skin disease 
manage their own condition however, it is estimated that skin disease is the fourth 
commonest reason for a GP consultation,  including 5% of cases which are 
subsequently referred to secondary care (DoH 2007).  
 
Until recently most skin conditions have been managed either by general practitioners 
(GP) or in secondary care by specialist dermatologists (British Association of 
Dermatologists & Royal College of Physicians 2008). However, although, the 
provision of services which are both flexible and accessible to patients, is a key 
priority of recent government policy in the United Kingdom (UK) (DoH 1999, DoH 
2000, DoH 2007), the demand on appointments in general practice and a shortage of 
dermatologists (Associate Parliamentary Group on Skin (APGS) 2002) means that 
doctors are now increasingly unable to meet the service demands of the high number 
of patients with these conditions. It is recognized that nurses have lead roles to play in 
the delivery of dermatology services (Courtenay & Carey 2006, DoH 2007), and that 
nurse prescribing is an important component of the services that they provide (DoH 
2007).  
 
Following a series of legislative changes between 1992 and 2006, nurses in the UK 
now enjoy extended prescribing rights, and virtually have the same prescribing rights 
as doctors (DoH 2006). Appropriately qualified nurses are able to undertake training 
enabling them to prescribe both as independent and supplementary prescribers. Nurse 
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Independent Prescribing (NIP) and Nurse Supplementary Prescribing (NSP) are two 
different modes of prescribing training for which is combined. Upon successful 
completion of the programme, nurses are able to use both independent and 
supplementary prescribing.  NIPs  are able to prescribe any licensed medicine (and 
some controlled drugs (CDs)) provided that it is within their area of competence 
(DoH 2006). Whilst any medicine (including unlicensed medicines and CDs) can 
similarly be prescribed by qualified NSPs (DoH 2003), this only takes place after 
assessment and diagnosis of the patients condition has been made by a doctor, and a 
Clinical Management Plan (CMP) (which includes a list of medicines from which the 
NSP is competent to prescribe) has been agreed between the nurse, doctor and patient. 
There are currently over 13,000 qualified NIP/NSPs across the UK (Nursing and 
Midwifery Council (NMC 2007)). 
 
Recent evidence suggests that nurses are frequently prescribing for skin conditions 
(Latter et al. 2005, Courtenay et al. 2007, Carey et al. 2007). A survey conducted in 
the UK in 2005 (Courtenay et al. 2006) found that nearly 75% of nurses qualified as 
NIPs/NSPs prescribe medicines for dermatology patients. The majority of these 
nurses are in primary care and prescribe between 6-10 items a week. Conditions for 
which they commonly prescribe include eczema, fungal infections, impetigo, acne, 
and psoriasis (Courtenay et al. 2007, Carey et al. 2007).However, there is no evidence 
exploring the impact of nurse prescribing on dermatology services.  
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BACKGROUND 
A review of the literature suggests that nurse-led care in the UK enhances the services 
that patients with dermatology conditions receive (Courtenay & Carey 2006). Cox and 
Walton (1998) in a review of medicines administered and supplied by nurses in  a 
dermatology department, distributed a questionnaire to 45 adult patients. In addition 
to improving access to treatment, the findings indicated that nurse-led care enabled 
patients to receive care from an expert, eliminating or deferring the need for a 
separate appointment with a GP or dermatologist. More recently, and in support of 
these findings, McEvoy (2004) reports on patient evaluations of a nurse-led 
dermatology advice clinic within the primary care setting. Information collected from 
patient questionnaires identified that less than 10% of patients were referred from the 
clinic to see a consultant dermatologist.  
 
Although not  looking at the configuration of dermatology services, one study has 
specifically explored how nurse prescribing contributes to  the delivery of services to 
patients (Carey & Courtenay 2007). In this survey of 439 NIP/NSPs, who prescribed 
for patients with diabetes, nurses worked in a variety of roles (i.e. nurse practitioners, 
specialist nurses and community matrons) and provided a range of services in both 
primary and secondary care. Over 90% of patients were based in the community, and 
more than 70% of participants used nurse prescribing to support services delivered in 
general practice.  
 
A number of  studies  based in the UK have also reported on the benefits of nurse 
prescribing. It is evident from this literature that both doctors and nurses believe nurse 
prescribing improves access to healthcare (Avery et al. 2004, Bradley et al. 2005, 
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Bradley & Nolan 2007, Courtenay & Berry 2007, Nolan & Bradley 2007, Ryan-
Woolley et al. 2007). For example, Avery et al. (2004), conducted interviews with six 
hospital doctors and six general practitioners in varied settings in one region in the 
UK, and reported that the main perceived benefits for patients were improved 
efficiency and fewer delays in waiting for prescriptions to be signed. Additionally, 
Bradley & Nolan (2007), interviewed 45 qualified nurse prescribers, and reported 
ease of access to medication, increased availability of the nurse, and continuity of care 
were some of the benefits of independent and supplementary prescribing.   
 
Although the evidence is generally positive, concerns have been raised surrounding 
the provision of support, access to continuing professional development (CPD) 
(Humphries & Green 2000, Otway 2001, Bradley et al. 2007, Carey et al. 2007), and 
the extra demands prescribing creates by increasing nurses workload with little 
capacity to delegate (Bradley & Nolan 2007, Nolan & Bradley 2007, Ryan-Woolley 
et al. 2007).  
 
There is no evidence available which that explores stakeholders views on the effect 
that nurse prescribing has on the services that patients with dermatology conditions 
receive. This is important given the increasing number of patients with skin 
conditions and the high number of nurses who prescribe for them. 
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 THE STUDY 
Aim 
The aim was to explore stakeholder views on the impact of nurse prescribing on 
dermatology services.   
 
METHODOLOGY 
This paper reports on a set of interview data from a larger study, the aim of which was 
to explore the treatment management of patients with dermatological conditions by 
NIPs/NSPs. A national survey of NIPs/NSPs, who prescribed medicines for 
dermatology patients was conducted to address  the initial phase of this resaerch, the 
findings of  which have been reported previously (Courtenay et al. 2007, Carey et al. 
2007, Courtenay et al. 2006). 
 
 
The second phased of the research adopted a collective case study approach  (Stake 
1995), multiple methods of data collection (i.e. interviews, questionnaires, video 
consultations and prescriptions) were used to capture a range of  perspectives. Data 
collected from the national survey were used to select case studies (n=10) of practice 
settings in which nurses prescribed medicines for dermatology patients.  This paper 
reports on interview data collected from nurse prescribers, administrative staff, 
doctors and non-nurse prescribers. Additional findings from phase 2 of the research 
(including questionnaires, video consultations and prescriptions) are reported 
elsewhere (Courtenay et al. 2008).  
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Participants  
A number of criteria which emerged from the findings of the survey were used to 
purposively select cases in different geographical locations in England, and represent 
dermatology services provided in primary and secondary care. Case studies included 
Dermatology Specialist Nurses (n=4) and a Dermatology Nurse Consultant working 
across both primary and secondary care. Practice Nurses (n=3) (two practice nurses 
worked in one site) and  Nurse Practitioners (n=2) working in primary care (see Table 
1).  Within each case study site data was collected from a purposive sample of 
doctors, who supervised or supported a nurse prescriber, administrative staff and non-
prescribing nurses who worked alongside the nurse prescriber.  
 
 
DATA COLLECTION 
Case study data collection took place between June 2006 and September 2007. A total 
of 40 semi-structured interviews were conducted with nurse prescribers and members 
of the healthcare team (i.e. doctors, administrative staff and non-prescribing nurses). 
The face to face interviews were held in mutually convenient locations at the case 
study sites. Interviews lasted between 10-40 minutes and all participants gave 
permission for the interviews to be audio-taped and transcribed. All interviews were 
conducted by a researcher from the University of Reading.  
 
 
The interview schedule was informed by a literature review (Courtenay & Carey 
2006) and findings from a national survey exploring nurse prescribing in dermatology 
(Courtenay et al. 2006). The interview schedule covered general views and 
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experiences of NIP and NSP for dermatology patients, role changes resulting from 
prescribing, difficulties arising from prescribing, support and supervision. 
 
Ethical considerations 
Approval to undertake study was granted by the National Health Service (NHS) 
research ethics committee and the local relevant Primary Care Trust (PCT) or hospital 
trust.  
 
Participants in the national survey who indicated that they may be interested in 
participating in phase 2 of the research, and met the sampling criteria were initially 
approached. Once an interest and managerial support were confirmed, participants 
were given an introductory letter and the project protocol. Other members of the 
healthcare team were also approached and asked to participate in an interview. A 
researcher then arranged dates, and prior to the interview participants had the 
opportunity to ask any questions. Participants were informed that all responses would 
be anonymised.  
 
DATA ANALYSIS 
A thematic analysis, a recognised method used to identify, analyse, and report themes 
and patterns within interview data, was conducted (Braun & Clark 2006). ATLAS.ti, a 
qualitative data analysis software package, was used to aid initial coding and 
identification of patterns across the data. This was followed by further discussion and 
interpretation between two researchers (NC & KS) to identify areas of data 
convergence and overall interpretation of themes. Saturation of the data was achieved.  
Once themes were developed the data was analysed by type of health care 
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professional, and setting (i.e. specialist versus nurses in general practice), to identify 
any differences.  
Rigour 
For the purposes of this paper data from nurse prescribers, administrative staff, 
doctors and non-nurse prescribers were selected as a unit of analysis. The 
comprehensiveness of the findings was enhanced by triangulation of data sources to 
elicit the various and divergent views from each group of health care professionals.   
Two skilled qualitative researchers independently assessed the transcripts and 
enhanced reliability of the findings. Minor differences in assessment were 
consolidated through discussion. Interim findings were presented at a nurse 
prescribing conference held at the University of Reading and the British Dermatology 
Nursing Group (BDNG) nurse prescribing sub-committee, delegates and members of 
whom were involved in data collection at case study sites.  
FINDINGS 
Across the 10 case study sites 40 interviews were conducted including nurse 
prescribers (n=11), doctors (n=12), administrative staff (n=11) and non-nurse 
prescribers (n=6) (see Table 1). However, a problem with audio equipment with a 
practice nurse meant only 39 interviews were transcribed and analysed. 
 
Nurses working in general practice (nurse practitioners and practice nurses) 
predominantly dealt with minor skin conditions and patients requiring one-off 
treatments (e.g. fungal infections & impetigo). By contrast, specialist nurses generally 
treated patients with chronic skin conditions who required long-term care (e.g. 
eczema, psoriasis & acne). 
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The analysis resulted in two themes relating to the contribution of nurse prescribing to 
the delivery of dermatological services: modernising health services and 
organizational issues.   The two themes (each with a number of sub-themes) were 
distinct and demonstrated that participants identified a number of areas where nurse 
prescribing had enhanced the provision of dermatology services. However, 
participants reported a number of organizational issues which ultimately restricted the 
success of the initiative.  
 
Quotations are used to illustrate themes in the analysis. To protect anonymity of 
participants, references to names or places have been removed from these quotations. 
Names have been replaced by an ‘x’ where appropriate. Quotations are followed by a 
code referring to the case study site number (cs) and the participant group of the 
person quoted. Participant groups have been abbreviated to Dr=doctor, NP = nurse 
prescriber, NNP =non prescribing nurse, AS=administrative or reception staff. 
 
A.  MODERNISING SERVICES 
Faster and more efficient service 
The most immediately apparent benefit of nurse prescribing reported was the 
improved speed and efficiency of access to medication and services for patients. In 
general practice (GP), changes to appointment systems had predominantly been 
influenced by the introduction of Advanced Access (an approach to booking 
appointments which ensures patients have access within 48 hours (DoH 2000)), and 
nurse led minor illness clinics. For patients who attended the hospital/ specialist 
community clinic, waiting list times had been reduced by the introduction of nurse-led 
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clinics. The capacity to prescribe was reported to be integral to the success of the 
nurse led initiatives: 
 
I think there is a definite advantage for the patient because they would be seen 
earlier than if they had to wait to go onto the doctors list because the waiting 
list would be longer. (cs3AS1) 
 
Participants frequently reported how services were dependent upon nurse prescribing. 
This was particularly evident in the dermatology clinics. Doctors, both specialists and 
general practitioners, reported that historically clinics had always been overbooked. In 
the cases where nurse-led clinics had been introduced, there simply was no capcity for 
these services to be managed by a doctor:  
 
When I have a patient that I know can be followed up by a Nurse Practitioner I 
am thrilled because I have got no room in my follow-up clinics.  So what I 
have actually done is become dependent.  I mean if the Nurse Practitioner in 
this department was withdrawn I would not be able to look after the patients 
under my care. (cs3Dr1) 
 
Improved Access 
Participants reported how nurse prescribing had effectively increased the number of 
ways a patient could receive their care. The ability to prescribe combined with the 
increased availability of appointments and wider range of clinic settings was reported 
by AS, across the case study sites, to have effectively increased patient choice with 
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respect to times of appointments and in deciding which health care professional to 
consult:  
 
 
Because they can see X [nurse prescriber] they do see ‘X’, you know, to get a 
course of antibiotics or some cream or whatever.  They will see X and come in 
and see her for whatever reason. (cs7AS) 
 
Nurses were also praised for their approachability and ability to build rapport with 
patients: 
 
some patients find it less daunting to chat to a member of nursing staff than a 
doctor because, even though I’m quite approachable when I am actually seeing 
a patient I am usually in a room with two medical students, with SHO’s 
[senior house officer] and Registrars coming in and out, and the quality of 
environment is lost in that sense. (cs3Dr1) 
 
 
AS in general practice reported that in some instances patients preferred to see the 
nurse (all female) particularly if they perceived the problem to be minor or sensitive 
in nature. Commenting on patients in general, rather than those only with a skin 
complaint, they additionally reported that most appeared to have accepted, that for 
same day appointments, it was likely that a nurse would deal with their problem:  
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I think the patients sometimes don’t mind going to the nurse rather than going 
to the doctor sometimes. They are quite happy to see if the x [nurse prescriber] 
can deal with it.  They don’t want to ‘bother the doctor with something like 
that’. (cs2AS1) 
Skill mix and flexible working 
Nurse prescribing was reported to support skill mix and facilitate different ways of 
team working. Participants reported a mixed impact on the individual workloads of 
team members. Some doctors reported that the content of their workload had changed. 
For example, GPs reported that they now saw more complex patients (although not 
those with dermatology problems) and fewer patients with minor illness (including 
those with skin conditions). In addition to an increased remit of new patients, another 
dermatology doctor similarly reported that they also saw more complex patients: 
 
It has changed the nature of our work. X see’s a lot of her own patients in 
follow ups, which obviously creates more space, it is about properly using 
skills. Therefore I am more available for using my diagnostic skills in new 
patients as a result. (cs10Dr1) 
 
The main impact of nurse prescribing reported by all doctors was less interruptions 
and less signing of prescriptions for patients they had not fully assessed: 
 
Previously she would come and say this is what they need and I would just 
sign at the bottom, so it makes much more sense if I am not seeing the patient 
for her to be signing the prescriptions. (cs1Dr) 
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There were examples where changes to the structure of the team had occurred, such as 
the introduction of Health Care Assistants:  
 
If they [nurse prescribers] are doing more extended roles then somebody else 
must be doing them [more traditional tasks]. I think there has been a push of 
those tasks down the hierarchy to health care assistants. (cs3Dr1) 
 
Additionally one AS, who also worked in the GP out of hours services, commented on 
a reduction in the number of doctors: 
We used to have more doctors and now we have less doctors, because we have 
more nurse prescribers, so it does make a difference to the team. The nurse 
practitioner stands in place of the GP now. (cs1AS) 
 
Nurse prescribing was thought by doctors and AS to support more efficient team 
working because of the speed and convenience of having a nurse prescriber at hand. 
In this respect, work life was made easier for team members by the additional 
capacity offered by nurse prescribing: 
 
Actually the nurses can’t do it all and the doctors can’t do it all, so actually 
you need a team and that is what we have developed here. (cs9Dr3) 
Nurse Supplementary Prescribing    
In each of the specialist dermatology units NSP was used in the management of 
systemic treatments for patients with acne and psoriasis. Although the process of 
getting CMPs approved through hospital committees was reported to be time 
consuming, NSP was reported to provide an ideal mechanism to support a consistent 
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approach to care if the nurse involved in the clinic changed. It also enabled nurses to 
continue treating patients who required systemic therapy for the management of their 
condition: 
 
Most of our nurses use Clinical Management Plans.  The reason for that is 
because it makes it easier for people in the future who follow them to fit into 
the protocol that we have got. (cs3Dr1) 
 
B. ORGANIZATIONAL ISSUES 
Ceiling effect 
There was some evidence of a ceiling effect whereby once nurse prescribers were 
working to capacity, no more benefits could accrue unless more resources were put in 
place. For example, one specialist nurse avoided prescribing complex medications or 
taking on high-risk patients because of the inability to take on the extra workload this 
entailed:  
Many of the drugs would have to be on a clinical management plan, as they 
are off license for children. I might review the child in between their 
consultation with the consultant, but they will have the [treatment] package in 
place, and purely I do not have enough clinical time in my life to fit it all in. 
(cs10NP)  
 
Lack of cover for nurse-led clinics, for both specialist and GP nurses,  during 
absences was highlighted as a problem by nurses and administrators. When this 
occurred, the benefits of nurse prescribing were lost as work patterns reverted to less 
efficient, old ways of working:  
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At the moment we only have one [nurse prescriber] so it makes it impossible if 
X is off sick for another nurse to do her clinic without a lot of stress for the 
other person. And also time consuming for the patients because that nurse 
might have all the knowledge and skills but they will have to get the doctor to 
come in because they have not done the prescribing course. (cs3NNP) 
 
Local restrictions 
Whilst nurse prescribing appeared to be firmly embedded in to service provision, 
several examples were given where organisational restrictions (within the hospital 
outpatient setting) had inhibited prescribing practice. Five nurses (4 specialists) had 
experienced some sort of local restriction on their prescribing. Two of these were 
local formulary restrictions on prescribing of emollients and in both cases the nurse 
was actively involved in revoking the restriction. One nurse was restricted to using 
hospital only prescriptions and two nurses had experienced procedural delays in 
getting approval to prescribe certain drugs:  
 
What has made prescribing difficult is the frustration because I run an X clinic 
and I should be able to prescribe Y in a Clinical Management Plan, but we 
have had an extremely long wait here from our Prescribing Lead to approve 
them.  Although we designed them, prepared them and they were ratified by 
our Consultants and then the Pharmacist. The process has taken about six 
months, and in that time I have seen so many patients on Y that I could have 
prescribed for. (cs8NP) 
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With regard to the formulary it has been difficult to get hold of the full 
formulary from the hospital, but we have been able to use pressure to get that. 
[] because I’ve prescribed I have actually influenced the emollient formulary 
in a much more patient friendly way by patient choices.  So it’s been positive 
in that way really. (cs3NP) 
 
Continued Professional Development and Support 
A range of support mechanisms were used by nurse prescribers including individual 
support from clinicians and peers, feedback and advice from non-medical prescribing 
groups, specialist networks and information from internet services, journals and 
conferences. Managers, particularly those supporting specialist nurses, were praised 
for their flexibility in allowing nurses time to develop the prescribing role. 
Pharmacists were noted as a source of information and advice and for their role in 
querying prescriptions.  
 
Nurse prescribers reported that access to CPD varied and there was a lack of training 
specific to dermatology. In addition to providing greater support for nurses working in 
the community, more guidance was requested on dermatology training: 
 
Ongoing support has gone very hit and miss. In the first year there were a few 
evening sessions on general stuff, not specific to dermatology. Now with all 
the reorganisation it has completely hit the bin and you don’t get any CPD 
from the employer. (cs1NP) 
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Monitoring and feedback 
It was important to nurses to have a means to discuss and confirm the appropriateness 
of their assessment and prescribing decisions, especially early on in their prescribing 
career when confidence was lacking. For example, one specialist nurse requested 
more structured support from clinicians early on in the prescribing role and another 
wanted measures to check that patterns of prescribing were evidence-based rather 
than due to habit:  
 
One of our registrars is going to set up teaching sessions for us, going through 
blood results specifically, but I think all this kind of thing could have been 
done at the start, with a much more multi-disciplined approach to it rather than 
‘right, you can prescribe, let’s start up the clinics for you (cs10NP) 
 
Formal support in the way of clinical supervision varied. Although nurses felt they 
could access a doctor if they needed; only 3 nurses had regular clinical supervision 
sessions.  A greater number of the specialist nurses had formal prescribing support 
meetings in place. For others, (including both GP and some specialist nurses) such 
support had once existed but had stopped, or was currently being planned but was not 
yet in place.  
 
Formal feedback from Prescribing Analysis & Cost (PACT) data, audit or other 
clinical governance procedure was also slow to develop. Whereas some nurses had 
just started to receive information on their prescribing patterns, others resorted to 
keeping records of their own prescribing practice because they were not receiving any 
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data on this.  Others were aware that their prescribing decisions were being audited 
but having had no feedback on this, assumed that no problems had arisen:  
 
I don’t get the PACT data. All they [prescription pricing authority] can do is to 
provide data based on the post code. So I can get it for what the doctor and I 
both prescribe, but I can’t get it for me. That’s why I keep a copy of what I 
prescribe. (cs1NP) 
 
DISCUSSION 
This study is the first to specifically report on the impact of nurse prescribing on the 
configuration of dermatology services, and represent stakeholder views from a range 
of practice settings.  
 
Our findings suggest that nurse prescribing enabled nurses to make more effective use 
of their knowledge and skills, overcome delays in treatment and provide faster access 
to medications. Nurses were less dependent upon doctors, and doctors were no longer 
asked to sign prescriptions for patients they had not assessed. Nurses and doctors were 
able to work more efficiently which was felt to enhance the quality of care and 
services provided. These findings support the aims of recent UK government policy  
(DoH 1999, DoH 2000, DoH 2006), and reiterate the contribution that nurse 
prescribing can make to the delivery of dermatology services (Carey & Courtenay 
2006, DoH 2007).   
  
In this study, improvements to services were considered  particularly important as it is 
recognised that doctors are increasingly unable to meet the demands of dermatology 
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patients (APGS 2002, DoH 2007). Nurse prescribing effectively increased the number 
of appointments where patients could receive care, and their medication, in a more 
timely fashion. Furthermore, there was evidence that these services were now 
dependent upon the capacity of the nurse to prescribe medicines. In general practice, 
(where nurses predominantly dealt with minor skin conditions), this was primarily 
achieved by the capacity of nurses to prescribe medicines in the already established 
minor illness clinics. By contrast the affect on the configuration of services offered by 
specialist nurses (the majority of whom tended to deal with chronic skin conditions) 
was more dramatic. For example, NSP provided an ideal mechanism for nurses to 
work in teams and manage patients who required more complex medications. In 
addition, the ability to prescribe as an NIP also supported more effective skill mix and 
flexible working. Nurses were able to work independently, without the presence of a 
medical prescriber, and as a result new clinics and nurse led services had been 
introduced in both dermatology out-patients and primary care. Realignment of 
doctor’s workloads were reported as the number of patients that consulted GPs for a 
skin condition reduced, and  specialist dermatology doctors increasingly saw patients 
with more complex skin conditions. These findings provide some insight into the 
contribution that nurses who have the capacity to prescriber can make to UK 
dermatology services. They also support findings recently reported by Carey & 
Courtenay (2007) who identified that over 70% of nurses who prescribed for patients 
with diabetes used their ability to prescribe to support services delivered in general 
practice.  
 
The fact that NSP was used to prescribe complex medicines by specialist nurses (who 
had extensive knowledge and skills in this area), provides some evidence that 
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supplementary prescribing is a useful mechanism to treat patients with complex 
conditions, where a team approach to care is necessary.  
 
Nurse prescribers reported that they made use of variety of resources for support and 
development. Participants accessed support from clinicians and peers, non-medical 
prescribing groups, specialist networks, information from journals and conferences, a 
need for more relevant dermatology courses, which included information on 
polypharmacy, drug interactions, and interpreting blood tests was also expressed. 
Access and availability to support and CPD for the prescribing role however, were 
inconsistent across the case study sites. Whilst this is in contrast to recent government 
guidelines (DoH 2006), which stipulate that the employer should ensure that the 
practitioner has access to relevant  ongoing education and training provision,  
inadequacies in the provision of support, feedback, audit and CPD have been 
previously reported in the literature (Humphries & Green 2000, Otway 2001, Latter et 
al. 2005, Courtenay et al. 2007, Courtenay et al. 2006). This is important as a lack of 
specialist knowledge, support and poor access to CPD, have been reported to affect 
the frequency with which nurses prescribe (Otway 2001, Latter et al. 2005, Carey et 
al. 2007). In order that nurses can continue to develop confidence and competence in 
their prescribing role, it is evident that the provision of appropriate dermatology 
courses, access to CPD and formal feedback are areas that need to be developed by 
education providers, and more formally embraced by managers within each 
organisation.  
 
The success of the prescribing initiative, particularly for specialist nurses, was 
affected by a lack of capacity to undertake more work or develop services further. The 
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issue of capacity and how it can restrict practice has previously been reported in the 
literature (Nolan & Bradley 2007, Bradley & Nolan 2007). Lack of capacity in this 
context was due increasing workloads prescribing created and the small number of 
nurse prescribers in each case study site.  Whilst there are obvious difficulties in 
funding health care, if the full potential of nurse prescribing is to be realised the wider 
implications of supporting the prescribing role need to be considered by those 
involved with the strategic planning and organisation of services. 
 
Limitations 
This was a self-reporting study of stakeholders who worked with nurses that provided 
services to patients with dermatology conditions. Their views are therefore likely to 
be biased towards supporting nurse prescribing. We also acknowledge that the study 
is limited to the views of stakeholders working in this clinical area. In order that the 
views of dermatology patients and the impact of nurse prescribing on service delivery 
can be evaluated using different research methodologies, further research is therefore 
required.   
 
CONCLUSION 
Nurse prescribing is successfully being used to support and deliver a range of services 
to dermatology patients.  Stakeholders reported that both patients and staff had 
benefited by the adoption of this role by nurses.  However issues over support and 
access to CPD, and capacity of the workforce were identified as potential barriers 
which could affect the contribution of nurse prescribing to dermatology patients.   
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 Table 1: Data collected from each case study site  
Case 
Study 
Job Title Number of 
nurses 
Interviews 
Nurse 
prescriber 
Doctor Admin staff Non-nurse 
prescriber 
1 DSN:  1 1 1 1 X 
2 PN 2 2 1 2 1 
3  DSN 1 1 1 1 1 
4 NP 1 1 1 1 X 
5 NP  1 1 2 1 X 
6 PN 1 1 1 1 1 
7 PN 1 1 X 1 1 
8 DSN 1 1 1 1 1 
9 DNC 1 1 3 1 1 
10 DSN 1 1 1 1 X 
Total 11 11 12 11 6 
 
Code DSN=Dermatology Specialist Nurse, PN=Practice Nurse, NP= Nurse Practitioner, DNC 
Dermatology Nurse Consultant 
 
